By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Advaxis, Inc. 

The Technology Centre of New Jersey
675 U.S. Route One, South
North Brunswick  New Jersey  08902   U.S.A.
Phone: 732-545-1590 Fax: 732-545-1084


SEARCH JOBS

Advaxis is a clinical-stage biotechnology company developing cancer immunotherapies that enlist the body’s own immune system to fight cancer.

YEAR FOUNDED:

2002

LEADERSHIP:

CEO: Daniel O’Connor

CFO: Sara Bonstein

CSO (Scientific): Robert Petit

JOBS:

Please click here for Advaxis job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.

FOLLOW ADVAXIS:



Key Statistics


Email:
Ownership: Public

Web Site: Advaxis
Employees:
Symbol: ADXS
 



Industry
Biotechnology






Company News
Advaxis (ADXS)' Resurrection and the Man Behind It All 8/22/2016 4:05:24 PM
Advaxis (ADXS) To Participate In Cervivor School 8/19/2016 6:58:26 AM
Advaxis (ADXS) Secures A $30M Direct Placement Financing To Healthcare Specialist Investors 8/16/2016 10:29:44 AM
Advaxis (ADXS) Announces That Phase II Head And Neck Cancer Study With AXAL Advances To Second Stage 8/11/2016 11:07:07 AM
Amgen (AMGN) Forges Pre-clinical R&D Pact Worth $540 Million With Advaxis (ADXS) 8/2/2016 6:29:49 AM
Advaxis (ADXS) Release: Phase I/II Combination Trial Of AXAL And Durvalumab Completes Second Dose-Escalation Cohort 7/26/2016 8:43:41 AM
Advaxis (ADXS)’ AXAL Receives Fast Track Designation By The FDA As Adjuvant Therapy For High-Risk Locally Advanced Cervical Cancer Patients 7/21/2016 8:06:22 AM
European Medicines Agency Committee Classifies Advaxis (ADXS)’ Axalimogene Filolisbac As An Advanced-Therapy Medicinal Product 7/18/2016 8:44:11 AM
Advaxis (ADXS) Appoints Ranya Dajani As Vice President, Corporate Development 7/12/2016 7:56:45 AM
Advaxis (ADXS) To Present At Cantor Fitzgerald’s 2nd Annual Healthcare Conference 7/8/2016 10:17:34 AM
12345678910...
//-->